The aim of the study is to compare the efficacy and safety of commercially available low-dose combination of three antihypertensive drugs versus commercially available fixed high-dose combination of two antihypertensive drugs in arterial hypertension
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with arterial hypertension resistant to monotherapy
